Page last updated: 2024-11-06

prednisolone and Cheiralgia Paresthetica

prednisolone has been researched along with Cheiralgia Paresthetica in 2 studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Research Excerpts

ExcerptRelevanceReference
"Sarcoidosis is a multisystem granulomatous disease of unknown etiology, with prevalence ranging from 1 to 50 per 100,000."1.40Neurosarcoidosis presenting as mononeuritis multiplex. ( Irwin, RW; Mattie, R, 2014)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mattie, R1
Irwin, RW1
Malipeddi, A1
Reddy, VR1
Kallarackal, G1

Reviews

1 review available for prednisolone and Cheiralgia Paresthetica

ArticleYear
Posterior interosseous nerve palsy: an unusual complication of rheumatoid arthritis: case report and review of the literature.
    Seminars in arthritis and rheumatism, 2011, Volume: 40, Issue:6

    Topics: Arthritis, Rheumatoid; Databases, Bibliographic; Elbow Joint; Glucocorticoids; Humans; Magnetic Reso

2011

Other Studies

1 other study available for prednisolone and Cheiralgia Paresthetica

ArticleYear
Neurosarcoidosis presenting as mononeuritis multiplex.
    American journal of physical medicine & rehabilitation, 2014, Volume: 93, Issue:4

    Topics: Central Nervous System Diseases; Edema; Forearm; Glucocorticoids; Humans; Lymphatic Diseases; Magnet

2014